[go: up one dir, main page]

AR104502A1 - PROCEDURE FOR THE PREPARATION OF 2- {4- [2 - ({[2- (4-CHLOROPHENYL) -1,3-TIAZOL-4-IL] METHYL} SULFANIL) -3,5-DICIAN-6- (PIRROLIDIN- 1-IL) PIRIDINA-4-IL] PHENOXI} ETIL-L-ALANIL-L-ALANINATO-MONOHIDROCLORURO - Google Patents

PROCEDURE FOR THE PREPARATION OF 2- {4- [2 - ({[2- (4-CHLOROPHENYL) -1,3-TIAZOL-4-IL] METHYL} SULFANIL) -3,5-DICIAN-6- (PIRROLIDIN- 1-IL) PIRIDINA-4-IL] PHENOXI} ETIL-L-ALANIL-L-ALANINATO-MONOHIDROCLORURO

Info

Publication number
AR104502A1
AR104502A1 ARP160101245A ARP160101245A AR104502A1 AR 104502 A1 AR104502 A1 AR 104502A1 AR P160101245 A ARP160101245 A AR P160101245A AR P160101245 A ARP160101245 A AR P160101245A AR 104502 A1 AR104502 A1 AR 104502A1
Authority
AR
Argentina
Prior art keywords
chlorophenyl
methyl
monohidrocloruro
dician
alaninato
Prior art date
Application number
ARP160101245A
Other languages
Spanish (es)
Inventor
Becker Guido
Keil Birgit
Dr Olenik Britta
Dr Heilmann Werner
Dr Mais Franz-Josef
Original Assignee
Bayer Pharma Aktiegesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma Aktiegesellschaft filed Critical Bayer Pharma Aktiegesellschaft
Publication of AR104502A1 publication Critical patent/AR104502A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Reivindicación 1: 2-{4-[2-({[2-(4-clorofenil)-1,3-tiazol-4-il]metil}sulfanil)-3,5-diciano-6-(pirrolidin-1-il)piridina-4-il]fenoxi}etil-L-alanil-L-alaninato-monohidrocloruro de la fórmula (1) en forma cristalina de la modificación I caracterizado porque el difractograma de rayos X del compuesto muestra un pico máximo del ángulo 2q en 6.5, 8.7 y 24.3.Claim 1: 2- {4- [2 - ({[2- (4-chlorophenyl) -1,3-thiazol-4-yl] methyl} sulfanyl) -3,5-dicyano-6- (pyrrolidin-1- il) pyridine-4-yl] phenoxy} ethyl-L-alanyl-L-alaninate-monohydrochloride of the formula (1) in crystalline form of modification I characterized in that the X-ray diffractogram of the compound shows a maximum peak of angle 2q in 6.5, 8.7 and 24.3.

ARP160101245A 2015-05-06 2016-05-02 PROCEDURE FOR THE PREPARATION OF 2- {4- [2 - ({[2- (4-CHLOROPHENYL) -1,3-TIAZOL-4-IL] METHYL} SULFANIL) -3,5-DICIAN-6- (PIRROLIDIN- 1-IL) PIRIDINA-4-IL] PHENOXI} ETIL-L-ALANIL-L-ALANINATO-MONOHIDROCLORURO AR104502A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP15166606 2015-05-06

Publications (1)

Publication Number Publication Date
AR104502A1 true AR104502A1 (en) 2017-07-26

Family

ID=53283983

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP160101245A AR104502A1 (en) 2015-05-06 2016-05-02 PROCEDURE FOR THE PREPARATION OF 2- {4- [2 - ({[2- (4-CHLOROPHENYL) -1,3-TIAZOL-4-IL] METHYL} SULFANIL) -3,5-DICIAN-6- (PIRROLIDIN- 1-IL) PIRIDINA-4-IL] PHENOXI} ETIL-L-ALANIL-L-ALANINATO-MONOHIDROCLORURO

Country Status (1)

Country Link
AR (1) AR104502A1 (en)

Similar Documents

Publication Publication Date Title
DK3651766T3 (en) 4-(4-(4-(((2-(2,6-DIOXOPIPERIDIN-3-YL)-L-OXOISOINDOLIN-4-YL)OXY)METHYL)BENZYL)PIPERAZIN-L-YL)-3-FLUOROBENZONITRILE AS ANTI-PROLIFERATIVE COMPOUND
ZA201807105B (en) Treatment of a hematologic malignancy with 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
MX376106B (en) NEW PYRIDAZONES AND TRIAZINONES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION.
MA39749A (en) Piperidine-dione derivatives
HUE055508T2 (en) Adjusting drive for furniture parts
HUE047666T2 (en) Process for the preparation of 2- [4- (4-chlorophenoxy) -2- (trifluoromethyl) phenyl] -1- (1,2,4-triazol-1-yl) -2-propanol
HUE056922T2 (en) 2-Substituted aminonaphtho [1,2-D] imidazol-5-one compounds or pharmaceutically acceptable salts thereof
MA40059A (en) Phosphatidylinositol 3-kinase inhibitors
EP3342768A4 (en) [4- (1,3,3-TRIMETHYL-2-OXO-3,4-DIHYDRO-1H-QUINOXALIN-7-YL) PHENOXY] ETHYLOXY COMPOUND OR ITS SALT
EP3735243A4 (en) Isotopologues of 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
EP3492468A4 (en) Heterocyclic compound as jak inhibitor, and salts and therapeutic use thereof
EP3490745A4 (en) CUTTING TOOL COATED WITH MULTILAYER HARD FILM
EP4491223A3 (en) Compound for use in the treatment of neurogenic orthostatic hypotension
PH12017502010A1 (en) Process for the preparation of 2-{4-[2-({[2-(4-chlorophenyl)-1,3-thiazol-4-yl]methyl}sulfanyl)-3,5-dicyano-6-(pyrrolidin-1-yl)pyridin-4-yl]phenoxy}ethyl-l-alanyl-l-alaninate monohydrochloride
AR104502A1 (en) PROCEDURE FOR THE PREPARATION OF 2- {4- [2 - ({[2- (4-CHLOROPHENYL) -1,3-TIAZOL-4-IL] METHYL} SULFANIL) -3,5-DICIAN-6- (PIRROLIDIN- 1-IL) PIRIDINA-4-IL] PHENOXI} ETIL-L-ALANIL-L-ALANINATO-MONOHIDROCLORURO
EP3541801A4 (en) 4-(6-(2-(2,4-difluorophenyl)-1.1-difluoro-2-hydroxy-3-(5-mercapto-1h
EP3553332A4 (en) ANGLE ADJUSTMENT TOOL
IL272835A (en) The salts of a compound and the crystalline forms thereof
SG11202100531RA (en) Novel thiazole derivatives and pharmaceutically acceptable salts thereof
EP3541797A4 (en) 4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(5-mercapto-1h
PL3274339T3 (en) Process for the preparation of 2- (homo)piperazine 1,3-benzothiazine-4-one hydrochlorides
ITUB20152424A1 (en) MACHINE AND PROCEDURE FOR THE PREPARATION OF A PASTOUS FOOD COMPOUND
EP3856188A4 (en) AMINOPYRIMIDINE COMPOUND
AR101109A1 (en) POLYMORPHIC FORM OF N- [2- (6-FLUORO-1H-INDOL-3-IL) ETIL] -3- (2,2,3,3-TETRAFLUOROPROPOXI) BENCILAMINE CHLORIDE
HK40006235A (en) Treatment of a hematologic malignancy with 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide

Legal Events

Date Code Title Description
FB Suspension of granting procedure